tradingkey.logo
tradingkey.logo
Suchen

Embecta Corp

EMBC
Zur Watchlist hinzufügen
3.350USD
-0.010-0.30%
Handelsschluss 07/02, 13:00ETKurse um 15 Minuten verzögert
198.75MMarktkapitalisierung
1.75KGV TTM

mehr Informationen über Embecta Corp Unternehmen

Embecta Corp. is a global medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. The Company has a portfolio of marketed products, including a variety of pen needles, syringes and safety injection devices. Its pen needles are sterile, single-use, medical devices, designed to be used in conjunction with pen injectors that inject insulin or other diabetes medications. It also sells safety pen needles, which have shields on both ends of the cannula that automatically deploy after the injection to help prevent needlestick exposure and injury during injection and disposal. Its traditional and safety pen needles are compatible and frequently used with pen injectors in the market. It sells sterile, single-use insulin syringes, which are used to inject insulin drawn from insulin vials. It also sells safety insulin syringes. It distributes its products through a variety of channels, including retail, hospitals and pharmacies.

Embecta Corp Informationen

BörsenkürzelEMBC
Name des UnternehmensEmbecta Corp
IPO-datumMar 21, 2022
CEOKurdikar (Devdatt)
Anzahl der mitarbeiter1850
WertpapierartOrdinary Share
GeschäftsjahresendeMar 21
Addresse300 Kimball Drive
StadtPARSIPPANY
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl07054
Telefon18624010000
Websitehttps://www.embecta.com/
BörsenkürzelEMBC
IPO-datumMar 21, 2022
CEOKurdikar (Devdatt)

Führungskräfte von Embecta Corp

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Devdatt (Dev) Kurdikar
Mr. Devdatt (Dev) Kurdikar
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
291.24K
+2.14%
Mr. Jacob (Jake) Elguicze
Mr. Jacob (Jake) Elguicze
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
114.14K
-2.21%
Mr. Jeffrey Z. (Jeff) Mann
Mr. Jeffrey Z. (Jeff) Mann
Senior Vice President, General Counsel, Product Development
Senior Vice President, General Counsel, Product Development
95.43K
-0.06%
Mr. Christopher R. (Chris) Reidy
Mr. Christopher R. (Chris) Reidy
Director
Director
55.24K
+41.35%
Mr. Robert J. (Bob) Hombach, CPA
Mr. Robert J. (Bob) Hombach, CPA
Independent Director
Independent Director
49.70K
+45.95%
Ms. Carrie L. Anderson
Ms. Carrie L. Anderson
Independent Director
Independent Director
49.70K
+45.96%
Dr. Milton Mayo Morris, Ph.D.
Dr. Milton Mayo Morris, Ph.D.
Independent Director
Independent Director
45.58K
+50.12%
Mr. Shaun Curtis
Mr. Shaun Curtis
Senior Vice President - Global Manufacturing, Supply Chain and Quality
Senior Vice President - Global Manufacturing, Supply Chain and Quality
34.01K
-18.45%
Ms. Jean Casner
Ms. Jean Casner
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
20.34K
-83.88%
Dr. Claire Pomeroy, M.D.
Dr. Claire Pomeroy, M.D.
Lead Independent Director
Lead Independent Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Devdatt (Dev) Kurdikar
Mr. Devdatt (Dev) Kurdikar
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
291.24K
+2.14%
Mr. Jacob (Jake) Elguicze
Mr. Jacob (Jake) Elguicze
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
114.14K
-2.21%
Mr. Jeffrey Z. (Jeff) Mann
Mr. Jeffrey Z. (Jeff) Mann
Senior Vice President, General Counsel, Product Development
Senior Vice President, General Counsel, Product Development
95.43K
-0.06%
Mr. Christopher R. (Chris) Reidy
Mr. Christopher R. (Chris) Reidy
Director
Director
55.24K
+41.35%
Mr. Robert J. (Bob) Hombach, CPA
Mr. Robert J. (Bob) Hombach, CPA
Independent Director
Independent Director
49.70K
+45.95%
Ms. Carrie L. Anderson
Ms. Carrie L. Anderson
Independent Director
Independent Director
49.70K
+45.96%

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von Embecta Corp?

Die fünf größten Anteilseigner von Embecta Corp sind: Mr. Devdatt (Dev) Kurdikar

Wie viele Institutionen halten Anteile an Embecta Corp (EMBC)?

Mit Stand vom 2026Q1 halten 791 Institutionen Anteile an Embecta Corp, mit einem Gesamtmarktwert von etwa 59.40M, was 100.13% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -4635325.00 gestiegen.

Was ist die größte Einnahmequelle von Embecta Corp?

Am 2026Q1 erzielte das Geschäft mit Pen Needles für Embecta Corp den höchsten Umsatz in Höhe von 185.50M, was 71.02% des Gesamtumsatzes entspricht.